Global Meningococcal Polysaccharide Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Meningococcal polysaccharide diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria.
According to our (Global Info Research) latest study, the global Meningococcal Polysaccharide Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Meningococcal Polysaccharide Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Meningococcal Polysaccharide Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Meningococcal Polysaccharide Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Meningococcal Polysaccharide Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Meningococcal Polysaccharide Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (US$/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Meningococcal Polysaccharide Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Meningococcal Polysaccharide Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Bio-Med, CanSinoBIO, Walvax Biotechnology and Chongqing Zhifei Biological, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Meningococcal Polysaccharide Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Meningococcal Polysaccharide Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Meningococcal Polysaccharide Vaccine, with price, sales, revenue and global market share of Meningococcal Polysaccharide Vaccine from 2018 to 2023.
Chapter 3, the Meningococcal Polysaccharide Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Polysaccharide Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Meningococcal Polysaccharide Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Meningococcal Polysaccharide Vaccine.
Chapter 14 and 15, to describe Meningococcal Polysaccharide Vaccine sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Meningococcal Polysaccharide Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Meningococcal Polysaccharide Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Meningococcal Polysaccharide Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Meningococcal Polysaccharide Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Meningococcal Polysaccharide Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Meningococcal Polysaccharide Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (US$/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Meningococcal Polysaccharide Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Meningococcal Polysaccharide Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Bio-Med, CanSinoBIO, Walvax Biotechnology and Chongqing Zhifei Biological, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Meningococcal Polysaccharide Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Polysaccharide Meningtitis AC
- Meningitis ACYW
- 6 Months-15Year
- over 3 Year
- over 2 Year
- over 3 Months
- Sanofi
- Bio-Med
- CanSinoBIO
- Walvax Biotechnology
- Chongqing Zhifei Biological
- Chengdu Kanghua Biological Products
- Changsheng Biotechnology
- CanSinoBIO
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Meningococcal Polysaccharide Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Meningococcal Polysaccharide Vaccine, with price, sales, revenue and global market share of Meningococcal Polysaccharide Vaccine from 2018 to 2023.
Chapter 3, the Meningococcal Polysaccharide Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Polysaccharide Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Meningococcal Polysaccharide Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Meningococcal Polysaccharide Vaccine.
Chapter 14 and 15, to describe Meningococcal Polysaccharide Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Meningococcal Polysaccharide Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Meningococcal Polysaccharide Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Polysaccharide Meningtitis AC
1.3.3 Meningitis ACYW
1.4 Market Analysis by Application
1.4.1 Overview: Global Meningococcal Polysaccharide Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 6 Months-15Year
1.4.3 over 3 Year
1.4.4 over 2 Year
1.4.5 over 3 Months
1.5 Global Meningococcal Polysaccharide Vaccine Market Size & Forecast
1.5.1 Global Meningococcal Polysaccharide Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Meningococcal Polysaccharide Vaccine Sales Quantity (2018-2029)
1.5.3 Global Meningococcal Polysaccharide Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Meningococcal Polysaccharide Vaccine Product and Services
2.1.4 Sanofi Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments/Updates
2.2 Bio-Med
2.2.1 Bio-Med Details
2.2.2 Bio-Med Major Business
2.2.3 Bio-Med Meningococcal Polysaccharide Vaccine Product and Services
2.2.4 Bio-Med Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bio-Med Recent Developments/Updates
2.3 CanSinoBIO
2.3.1 CanSinoBIO Details
2.3.2 CanSinoBIO Major Business
2.3.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
2.3.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 CanSinoBIO Recent Developments/Updates
2.4 Walvax Biotechnology
2.4.1 Walvax Biotechnology Details
2.4.2 Walvax Biotechnology Major Business
2.4.3 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
2.4.4 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Walvax Biotechnology Recent Developments/Updates
2.5 Chongqing Zhifei Biological
2.5.1 Chongqing Zhifei Biological Details
2.5.2 Chongqing Zhifei Biological Major Business
2.5.3 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product and Services
2.5.4 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Chongqing Zhifei Biological Recent Developments/Updates
2.6 Chengdu Kanghua Biological Products
2.6.1 Chengdu Kanghua Biological Products Details
2.6.2 Chengdu Kanghua Biological Products Major Business
2.6.3 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product and Services
2.6.4 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Chengdu Kanghua Biological Products Recent Developments/Updates
2.7 Changsheng Biotechnology
2.7.1 Changsheng Biotechnology Details
2.7.2 Changsheng Biotechnology Major Business
2.7.3 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
2.7.4 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Changsheng Biotechnology Recent Developments/Updates
2.8 CanSinoBIO
2.8.1 CanSinoBIO Details
2.8.2 CanSinoBIO Major Business
2.8.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
2.8.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 CanSinoBIO Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MENINGOCOCCAL POLYSACCHARIDE VACCINE BY MANUFACTURER
3.1 Global Meningococcal Polysaccharide Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Meningococcal Polysaccharide Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Meningococcal Polysaccharide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Meningococcal Polysaccharide Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Meningococcal Polysaccharide Vaccine Manufacturer Market Share in 2022
3.5 Meningococcal Polysaccharide Vaccine Market: Overall Company Footprint Analysis
3.5.1 Meningococcal Polysaccharide Vaccine Market: Region Footprint
3.5.2 Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
3.5.3 Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Meningococcal Polysaccharide Vaccine Market Size by Region
4.1.1 Global Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Meningococcal Polysaccharide Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Meningococcal Polysaccharide Vaccine Average Price by Region (2018-2029)
4.2 North America Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029)
4.3 Europe Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029)
4.5 South America Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Meningococcal Polysaccharide Vaccine Consumption Value by Type (2018-2029)
5.3 Global Meningococcal Polysaccharide Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Meningococcal Polysaccharide Vaccine Consumption Value by Application (2018-2029)
6.3 Global Meningococcal Polysaccharide Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Meningococcal Polysaccharide Vaccine Market Size by Country
7.3.1 North America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Meningococcal Polysaccharide Vaccine Market Size by Country
8.3.1 Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Meningococcal Polysaccharide Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Meningococcal Polysaccharide Vaccine Market Size by Region
9.3.1 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Meningococcal Polysaccharide Vaccine Market Size by Country
10.3.1 South America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Meningococcal Polysaccharide Vaccine Market Size by Country
11.3.1 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Meningococcal Polysaccharide Vaccine Market Drivers
12.2 Meningococcal Polysaccharide Vaccine Market Restraints
12.3 Meningococcal Polysaccharide Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Meningococcal Polysaccharide Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Meningococcal Polysaccharide Vaccine
13.3 Meningococcal Polysaccharide Vaccine Production Process
13.4 Meningococcal Polysaccharide Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Meningococcal Polysaccharide Vaccine Typical Distributors
14.3 Meningococcal Polysaccharide Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Meningococcal Polysaccharide Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Meningococcal Polysaccharide Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Polysaccharide Meningtitis AC
1.3.3 Meningitis ACYW
1.4 Market Analysis by Application
1.4.1 Overview: Global Meningococcal Polysaccharide Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 6 Months-15Year
1.4.3 over 3 Year
1.4.4 over 2 Year
1.4.5 over 3 Months
1.5 Global Meningococcal Polysaccharide Vaccine Market Size & Forecast
1.5.1 Global Meningococcal Polysaccharide Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Meningococcal Polysaccharide Vaccine Sales Quantity (2018-2029)
1.5.3 Global Meningococcal Polysaccharide Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Meningococcal Polysaccharide Vaccine Product and Services
2.1.4 Sanofi Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments/Updates
2.2 Bio-Med
2.2.1 Bio-Med Details
2.2.2 Bio-Med Major Business
2.2.3 Bio-Med Meningococcal Polysaccharide Vaccine Product and Services
2.2.4 Bio-Med Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bio-Med Recent Developments/Updates
2.3 CanSinoBIO
2.3.1 CanSinoBIO Details
2.3.2 CanSinoBIO Major Business
2.3.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
2.3.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 CanSinoBIO Recent Developments/Updates
2.4 Walvax Biotechnology
2.4.1 Walvax Biotechnology Details
2.4.2 Walvax Biotechnology Major Business
2.4.3 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
2.4.4 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Walvax Biotechnology Recent Developments/Updates
2.5 Chongqing Zhifei Biological
2.5.1 Chongqing Zhifei Biological Details
2.5.2 Chongqing Zhifei Biological Major Business
2.5.3 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product and Services
2.5.4 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Chongqing Zhifei Biological Recent Developments/Updates
2.6 Chengdu Kanghua Biological Products
2.6.1 Chengdu Kanghua Biological Products Details
2.6.2 Chengdu Kanghua Biological Products Major Business
2.6.3 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product and Services
2.6.4 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Chengdu Kanghua Biological Products Recent Developments/Updates
2.7 Changsheng Biotechnology
2.7.1 Changsheng Biotechnology Details
2.7.2 Changsheng Biotechnology Major Business
2.7.3 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
2.7.4 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Changsheng Biotechnology Recent Developments/Updates
2.8 CanSinoBIO
2.8.1 CanSinoBIO Details
2.8.2 CanSinoBIO Major Business
2.8.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
2.8.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 CanSinoBIO Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MENINGOCOCCAL POLYSACCHARIDE VACCINE BY MANUFACTURER
3.1 Global Meningococcal Polysaccharide Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Meningococcal Polysaccharide Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Meningococcal Polysaccharide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Meningococcal Polysaccharide Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Meningococcal Polysaccharide Vaccine Manufacturer Market Share in 2022
3.5 Meningococcal Polysaccharide Vaccine Market: Overall Company Footprint Analysis
3.5.1 Meningococcal Polysaccharide Vaccine Market: Region Footprint
3.5.2 Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
3.5.3 Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Meningococcal Polysaccharide Vaccine Market Size by Region
4.1.1 Global Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Meningococcal Polysaccharide Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Meningococcal Polysaccharide Vaccine Average Price by Region (2018-2029)
4.2 North America Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029)
4.3 Europe Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029)
4.5 South America Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Meningococcal Polysaccharide Vaccine Consumption Value by Type (2018-2029)
5.3 Global Meningococcal Polysaccharide Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Meningococcal Polysaccharide Vaccine Consumption Value by Application (2018-2029)
6.3 Global Meningococcal Polysaccharide Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Meningococcal Polysaccharide Vaccine Market Size by Country
7.3.1 North America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Meningococcal Polysaccharide Vaccine Market Size by Country
8.3.1 Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Meningococcal Polysaccharide Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Meningococcal Polysaccharide Vaccine Market Size by Region
9.3.1 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Meningococcal Polysaccharide Vaccine Market Size by Country
10.3.1 South America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Meningococcal Polysaccharide Vaccine Market Size by Country
11.3.1 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Meningococcal Polysaccharide Vaccine Market Drivers
12.2 Meningococcal Polysaccharide Vaccine Market Restraints
12.3 Meningococcal Polysaccharide Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Meningococcal Polysaccharide Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Meningococcal Polysaccharide Vaccine
13.3 Meningococcal Polysaccharide Vaccine Production Process
13.4 Meningococcal Polysaccharide Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Meningococcal Polysaccharide Vaccine Typical Distributors
14.3 Meningococcal Polysaccharide Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Meningococcal Polysaccharide Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Meningococcal Polysaccharide Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Meningococcal Polysaccharide Vaccine Product and Services
Table 6. Sanofi Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Recent Developments/Updates
Table 8. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 9. Bio-Med Major Business
Table 10. Bio-Med Meningococcal Polysaccharide Vaccine Product and Services
Table 11. Bio-Med Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bio-Med Recent Developments/Updates
Table 13. CanSinoBIO Basic Information, Manufacturing Base and Competitors
Table 14. CanSinoBIO Major Business
Table 15. CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
Table 16. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. CanSinoBIO Recent Developments/Updates
Table 18. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 19. Walvax Biotechnology Major Business
Table 20. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
Table 21. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Walvax Biotechnology Recent Developments/Updates
Table 23. Chongqing Zhifei Biological Basic Information, Manufacturing Base and Competitors
Table 24. Chongqing Zhifei Biological Major Business
Table 25. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product and Services
Table 26. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Chongqing Zhifei Biological Recent Developments/Updates
Table 28. Chengdu Kanghua Biological Products Basic Information, Manufacturing Base and Competitors
Table 29. Chengdu Kanghua Biological Products Major Business
Table 30. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product and Services
Table 31. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Chengdu Kanghua Biological Products Recent Developments/Updates
Table 33. Changsheng Biotechnology Basic Information, Manufacturing Base and Competitors
Table 34. Changsheng Biotechnology Major Business
Table 35. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
Table 36. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Changsheng Biotechnology Recent Developments/Updates
Table 38. CanSinoBIO Basic Information, Manufacturing Base and Competitors
Table 39. CanSinoBIO Major Business
Table 40. CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
Table 41. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. CanSinoBIO Recent Developments/Updates
Table 43. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Doses)
Table 44. Global Meningococcal Polysaccharide Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 46. Market Position of Manufacturers in Meningococcal Polysaccharide Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer
Table 48. Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
Table 49. Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
Table 50. Meningococcal Polysaccharide Vaccine New Market Entrants and Barriers to Market Entry
Table 51. Meningococcal Polysaccharide Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 53. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 54. Global Meningococcal Polysaccharide Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Meningococcal Polysaccharide Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Meningococcal Polysaccharide Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 57. Global Meningococcal Polysaccharide Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 58. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 59. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 60. Global Meningococcal Polysaccharide Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Meningococcal Polysaccharide Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Meningococcal Polysaccharide Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 63. Global Meningococcal Polysaccharide Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 64. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 65. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 66. Global Meningococcal Polysaccharide Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Meningococcal Polysaccharide Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Meningococcal Polysaccharide Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 69. Global Meningococcal Polysaccharide Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 70. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 71. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 72. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 73. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 74. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 75. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 76. North America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 79. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 80. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 81. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 82. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 83. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 84. Europe Meningococcal Polysaccharide Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Meningococcal Polysaccharide Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 87. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 88. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 89. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 90. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 91. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 92. Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 95. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 96. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 97. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 98. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 99. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 100. South America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 103. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 104. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 105. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 106. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 107. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 108. Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Meningococcal Polysaccharide Vaccine Raw Material
Table 111. Key Manufacturers of Meningococcal Polysaccharide Vaccine Raw Materials
Table 112. Meningococcal Polysaccharide Vaccine Typical Distributors
Table 113. Meningococcal Polysaccharide Vaccine Typical Customers
Table 1. Global Meningococcal Polysaccharide Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Meningococcal Polysaccharide Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Meningococcal Polysaccharide Vaccine Product and Services
Table 6. Sanofi Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Recent Developments/Updates
Table 8. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 9. Bio-Med Major Business
Table 10. Bio-Med Meningococcal Polysaccharide Vaccine Product and Services
Table 11. Bio-Med Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bio-Med Recent Developments/Updates
Table 13. CanSinoBIO Basic Information, Manufacturing Base and Competitors
Table 14. CanSinoBIO Major Business
Table 15. CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
Table 16. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. CanSinoBIO Recent Developments/Updates
Table 18. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 19. Walvax Biotechnology Major Business
Table 20. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
Table 21. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Walvax Biotechnology Recent Developments/Updates
Table 23. Chongqing Zhifei Biological Basic Information, Manufacturing Base and Competitors
Table 24. Chongqing Zhifei Biological Major Business
Table 25. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product and Services
Table 26. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Chongqing Zhifei Biological Recent Developments/Updates
Table 28. Chengdu Kanghua Biological Products Basic Information, Manufacturing Base and Competitors
Table 29. Chengdu Kanghua Biological Products Major Business
Table 30. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product and Services
Table 31. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Chengdu Kanghua Biological Products Recent Developments/Updates
Table 33. Changsheng Biotechnology Basic Information, Manufacturing Base and Competitors
Table 34. Changsheng Biotechnology Major Business
Table 35. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
Table 36. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Changsheng Biotechnology Recent Developments/Updates
Table 38. CanSinoBIO Basic Information, Manufacturing Base and Competitors
Table 39. CanSinoBIO Major Business
Table 40. CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
Table 41. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. CanSinoBIO Recent Developments/Updates
Table 43. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Doses)
Table 44. Global Meningococcal Polysaccharide Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 46. Market Position of Manufacturers in Meningococcal Polysaccharide Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer
Table 48. Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
Table 49. Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
Table 50. Meningococcal Polysaccharide Vaccine New Market Entrants and Barriers to Market Entry
Table 51. Meningococcal Polysaccharide Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 53. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 54. Global Meningococcal Polysaccharide Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Meningococcal Polysaccharide Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Meningococcal Polysaccharide Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 57. Global Meningococcal Polysaccharide Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 58. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 59. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 60. Global Meningococcal Polysaccharide Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Meningococcal Polysaccharide Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Meningococcal Polysaccharide Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 63. Global Meningococcal Polysaccharide Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 64. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 65. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 66. Global Meningococcal Polysaccharide Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Meningococcal Polysaccharide Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Meningococcal Polysaccharide Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 69. Global Meningococcal Polysaccharide Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 70. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 71. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 72. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 73. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 74. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 75. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 76. North America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 79. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 80. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 81. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 82. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 83. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 84. Europe Meningococcal Polysaccharide Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Meningococcal Polysaccharide Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 87. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 88. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 89. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 90. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 91. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 92. Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 95. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 96. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 97. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 98. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 99. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 100. South America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 103. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 104. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 105. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 106. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 107. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 108. Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Meningococcal Polysaccharide Vaccine Raw Material
Table 111. Key Manufacturers of Meningococcal Polysaccharide Vaccine Raw Materials
Table 112. Meningococcal Polysaccharide Vaccine Typical Distributors
Table 113. Meningococcal Polysaccharide Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Meningococcal Polysaccharide Vaccine Picture
Figure 2. Global Meningococcal Polysaccharide Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Polysaccharide Meningtitis AC Examples
Figure 5. Meningitis ACYW Examples
Figure 6. Global Meningococcal Polysaccharide Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Application in 2022
Figure 8. 6 Months-15Year Examples
Figure 9. over 3 Year Examples
Figure 10. over 2 Year Examples
Figure 11. over 3 Months Examples
Figure 12. Global Meningococcal Polysaccharide Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Meningococcal Polysaccharide Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Meningococcal Polysaccharide Vaccine Sales Quantity (2018-2029) & (K Doses)
Figure 15. Global Meningococcal Polysaccharide Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 16. Global Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Meningococcal Polysaccharide Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Meningococcal Polysaccharide Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Meningococcal Polysaccharide Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Meningococcal Polysaccharide Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 31. Global Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Meningococcal Polysaccharide Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 34. North America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 54. China Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Meningococcal Polysaccharide Vaccine Market Drivers
Figure 75. Meningococcal Polysaccharide Vaccine Market Restraints
Figure 76. Meningococcal Polysaccharide Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Meningococcal Polysaccharide Vaccine in 2022
Figure 79. Manufacturing Process Analysis of Meningococcal Polysaccharide Vaccine
Figure 80. Meningococcal Polysaccharide Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Meningococcal Polysaccharide Vaccine Picture
Figure 2. Global Meningococcal Polysaccharide Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Polysaccharide Meningtitis AC Examples
Figure 5. Meningitis ACYW Examples
Figure 6. Global Meningococcal Polysaccharide Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Application in 2022
Figure 8. 6 Months-15Year Examples
Figure 9. over 3 Year Examples
Figure 10. over 2 Year Examples
Figure 11. over 3 Months Examples
Figure 12. Global Meningococcal Polysaccharide Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Meningococcal Polysaccharide Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Meningococcal Polysaccharide Vaccine Sales Quantity (2018-2029) & (K Doses)
Figure 15. Global Meningococcal Polysaccharide Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 16. Global Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Meningococcal Polysaccharide Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Meningococcal Polysaccharide Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Meningococcal Polysaccharide Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Meningococcal Polysaccharide Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 31. Global Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Meningococcal Polysaccharide Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 34. North America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 54. China Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Meningococcal Polysaccharide Vaccine Market Drivers
Figure 75. Meningococcal Polysaccharide Vaccine Market Restraints
Figure 76. Meningococcal Polysaccharide Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Meningococcal Polysaccharide Vaccine in 2022
Figure 79. Manufacturing Process Analysis of Meningococcal Polysaccharide Vaccine
Figure 80. Meningococcal Polysaccharide Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
